4Ever Young

# 4Ever Young Franchise Intelligence Report

## Executive Summary

4Ever Young operates a rapidly growing anti-aging and wellness franchise with 59 US locations. The $354K-$828K investment is substantial, but the $1.4M median gross sales and ~$280K estimated owner earnings represent compelling unit economics. The franchise capitalizes on the booming wellness and aesthetics market, offering hormone therapy, medical aesthetics, and total body wellness services.

## The Business

4Ever Young provides anti-aging and wellness services including hormone replacement therapy (HRT), medical aesthetics (Botox, fillers, skin treatments), IV therapy, weight management, and total body wellness solutions. Founded in 2014 by Carlton Washington and Deniz Duygulu in Boca Raton, Florida. The business model targets affluent consumers seeking preventative health and aesthetic services, with recurring revenue from ongoing treatments.

## The Numbers

- **Total Investment**: $354,000 - $828,000 - **Franchise Fee**: $60,000 (discounts for veterans and multi-unit) - **Royalty**: 7% of Gross Revenue (with monthly minimums: $0 months 1-6, $2,500 months 7-12, $5,000 thereafter) - **Brand Development Fund**: 2% of gross revenue - **Net Worth Required**: $500,000 - **Liquidity Required**: $150,000 - **Median Gross Sales**: $1,403,404 - **Estimated Owner Earnings**: ~$280,681 - **Payback Period**: 4.0 - 6.0 years - **Locations**: 59 total (56 franchised, 3 corporate)

## System Health

59 locations with rapid growth indicates strong market demand for anti-aging services. Founded in 2014 and franchising more recently, the system is relatively young but scaling quickly. The presence of corporate-owned locations suggests the franchisor maintains operational expertise and skin in the game. The $1.4M median gross sales is impressive for a specialized wellness concept.

## Franchisee Experience

The business requires a medical director for clinical oversight but franchisees don't need medical backgrounds. The 7% royalty with graduated minimums provides relief during ramp-up. Training covers clinical protocols, sales processes, and operations. The recurring nature of services (monthly HRT, regular aesthetics appointments) creates predictable revenue streams once established.

## Risk Assessment

**LOW - Market Demand**: Anti-aging and wellness is a rapidly growing market driven by aging Baby Boomers and wellness-focused Millennials.

**MODERATE - Regulatory**: Medical aesthetics and hormone therapy operate in a regulated space requiring physician oversight and compliance.

**MODERATE - Investment Level**: $354K-$828K is a significant investment requiring careful financial planning.

**LOW - Unit Economics**: $1.4M median sales with ~20% owner earnings suggests strong profitability potential.

**MODERATE - Competition**: Competes with med spas, hormone clinics, and other anti-aging concepts.

## Competitive Position

Competes with other anti-aging franchises, independent med spas, hormone therapy clinics, and aesthetic practices. The comprehensive service offering (hormones + aesthetics + wellness) provides differentiation.

**Advantages**: - Strong disclosed unit economics ($1.4M median sales) - Recurring revenue from ongoing treatments - Growing market with demographic tailwinds - Multiple service lines reduce dependency

**Disadvantages**: - High investment requirement - Regulatory complexity requires medical oversight - Relatively young franchise system

## Validation Questions

1. What's the breakdown of revenue by service type (HRT vs. aesthetics vs. other)? 2. How do you recruit and retain the medical director and clinical staff? 3. What's the typical patient lifetime value and retention rate? 4. How long does it take to reach the median gross sales figure? 5. What's the patient acquisition cost and marketing strategy? 6. How do you handle state-specific regulations around hormone therapy? 7. What's the cash conversion cycle given insurance vs. cash-pay mix?

## Data Gaps

- Detailed profitability breakdown beyond owner earnings estimate - Franchisee satisfaction data not publicly available - Patient retention and lifetime value metrics - Geographic performance variations - Staff compensation and turnover data

## Verdict: STRONG

Compelling opportunity in a rapidly growing market with impressive disclosed unit economics. The $1.4M median gross sales and ~$280K owner earnings on a $354K-$828K investment represent attractive potential returns. Best suited for operators who can navigate the medical regulatory environment and have capital for the substantial investment. The recurring revenue model from ongoing treatments is particularly valuable.